Stock Track | Olema Pharmaceuticals Skyrockets 208.80% Pre-Market on JPMorgan's Bullish Price Target Hike

Stock Track

Nov 18, 2025

Shares of Olema Pharmaceuticals, Inc. (OLMA) are experiencing a dramatic surge in pre-market trading on Tuesday, soaring by an impressive 208.80%. This extraordinary movement comes on the heels of a significant upgrade from a major Wall Street firm.

JPMorgan, a leading investment bank, has raised its price target on Olema Oncology to $32 from $29, while maintaining an Overweight rating on the shares. This bullish stance from JPMorgan appears to be the primary catalyst behind the stock's meteoric rise. The firm's decision to adjust its models and increase the price target suggests growing confidence in Olema's potential in the oncology space.

The pre-market rally in Olema Pharmaceuticals' stock price underscores the significant impact that analyst opinions and price target changes can have on investor sentiment, particularly for biotech companies focused on innovative cancer treatments. As the market opens, investors will be closely watching to see if this momentum can be sustained throughout the regular trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1135615842"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1135615842\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1135615842?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-18 20:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1135615842","market":"hk","top_or_hot":-1,"title":"Stock Track | Olema Pharmaceuticals Skyrockets 208.80% Pre-Market on JPMorgan's Bullish Price Target Hike","media":"Stock Track","content":"<p>Shares of Olema Pharmaceuticals, Inc. (OLMA) are experiencing a dramatic surge in pre-market trading on Tuesday, soaring by an impressive 208.80%. This extraordinary movement comes on the heels of a significant upgrade from a major Wall Street firm.</p>\n\n<p>JPMorgan, a leading investment bank, has raised its price target on Olema Oncology to $32 from $29, while maintaining an Overweight rating on the shares. This bullish stance from JPMorgan appears to be the primary catalyst behind the stock's meteoric rise. The firm's decision to adjust its models and increase the price target suggests growing confidence in Olema's potential in the oncology space.</p>\n\n<p>The pre-market rally in Olema Pharmaceuticals' stock price underscores the significant impact that analyst opinions and price target changes can have on investor sentiment, particularly for biotech companies focused on innovative cancer treatments. As the market opens, investors will be closely watching to see if this momentum can be sustained throughout the regular trading session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Olema Pharmaceuticals Skyrockets 208.80% Pre-Market on JPMorgan's Bullish Price Target Hike</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Olema Pharmaceuticals Skyrockets 208.80% Pre-Market on JPMorgan's Bullish Price Target Hike\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-18 20:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Olema Pharmaceuticals, Inc. (OLMA) are experiencing a dramatic surge in pre-market trading on Tuesday, soaring by an impressive 208.80%. This extraordinary movement comes on the heels of a significant upgrade from a major Wall Street firm.</p>\n\n<p>JPMorgan, a leading investment bank, has raised its price target on Olema Oncology to $32 from $29, while maintaining an Overweight rating on the shares. This bullish stance from JPMorgan appears to be the primary catalyst behind the stock's meteoric rise. The firm's decision to adjust its models and increase the price target suggests growing confidence in Olema's potential in the oncology space.</p>\n\n<p>The pre-market rally in Olema Pharmaceuticals' stock price underscores the significant impact that analyst opinions and price target changes can have on investor sentiment, particularly for biotech companies focused on innovative cancer treatments. As the market opens, investors will be closely watching to see if this momentum can be sustained throughout the regular trading session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OLMA","symbol_name":"Olema Pharmaceuticals, Inc.","start_time":0,"source_url":"","article_id":"1135615842","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1135615842","pubTimestamp":1763469739,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Olema Pharmaceuticals, Inc. (OLMA) are experiencing a dramatic surge in pre-market trading on Tuesday, soaring by an impressive 208.80%. This extraordinary movement comes on the heels of a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OLMA":"Olema Pharmaceuticals, Inc."},"translate_title":"个股追踪|奥莱玛制药盘前暴涨208.80%因摩根大通看涨目标价上调","themeId":"63db4c8844cbc8a09577788eba75f618","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OLMA":1},"content_text":"Shares of Olema Pharmaceuticals, Inc. (OLMA) are experiencing a dramatic surge in pre-market trading on Tuesday, soaring by an impressive 208.80%. This extraordinary movement comes on the heels of a significant upgrade from a major Wall Street firm.\nJPMorgan, a leading investment bank, has raised its price target on Olema Oncology to $32 from $29, while maintaining an Overweight rating on the shares. This bullish stance from JPMorgan appears to be the primary catalyst behind the stock's meteoric rise. The firm's decision to adjust its models and increase the price target suggests growing confidence in Olema's potential in the oncology space.\nThe pre-market rally in Olema Pharmaceuticals' stock price underscores the significant impact that analyst opinions and price target changes can have on investor sentiment, particularly for biotech companies focused on innovative cancer treatments. As the market opens, investors will be closely watching to see if this momentum can be sustained throughout the regular trading session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}